US President Trump's 25% tariff plan on pharmaceuticals jeopardizes Indian pharma exports, making generics pricier and ...

As reported by ET last week, the drug pricing regulator had asked all retailers and dealers to display the current price list ...

创新药的开发过程充满了艰难与挑战。无论是临床前还是临床环节，制药公司面临的大多数是医患和科学家两个群体，这里面大量充斥着理性和人文的交织。在双十定律之下，能在一些相对较难的方向上去做一些突破，来完成前人未达到的治疗成就，仅靠着一些投融资上的对赌条款， ...

Microsoft 365 Copilot is an enhanced version of its bread-and-butter operating system that uses AI to enhance the user's experience across the company's product line (e.g., Microsoft Excel, Powerpoint ...

State Key Laboratory of Microbial Metabolism and School of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai 200240, China Zhangjiang Institute for Advanced Study, Shanghai Jiao ...

It also lets people export their presentations to a PowerPoint file for further editing or as a PDF. Presentations.ai specifically includes “guardrails” to assure enterprise customers it has a ...

DUBLIN, Ireland, Jan. 28, 2025 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions ...

The future of the Bay Area biotech firm Allakos was riding on one clinical trial, for a drug designed to treat the skin condition known as chronic spontaneous urticaria, or chronic hives.

State Key Laboratory of Microbial Metabolism, Joint International Research Laboratory of Metabolic & Developmental Sciences, School of Life Sciences & Biotechnology, and Zhangjiang Institute for ...

China-based biotech Ascentage Pharma has raised $126m in a US initial public offering (IPO), marking the first biotech IPO of 2025. The company sold 7,325,000 American Depositary shares at $17.25 ...

Sam Altman, pictured at President Donald Trump's inauguration, is contributing to another round of funding for Retro Biosciences. © 2025 Fortune Media IP Limited ...

Only one traditional preclinical biotech—Metagenomi—went public last year, compared to around a quarter of the biotechs that IPOed in 2020 and 2021, according to Surti. About two-thirds of the ...